Hematopoietic Stem Cell Transplantation in Patients With Chronic Kidney Disease
Authors:
- 1 November 2010
- journal article
- review article
- Published by Elsevier in Seminars in Nephrology
- Vol. 30 (6) , 602-614
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Graft-versus-host diseaseThe Lancet, 2009
- A Risk Score for Mortality after Allogeneic Hematopoietic Cell TransplantationAnnals of Internal Medicine, 2006
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTBlood, 2005
- Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patientsBone Marrow Transplantation, 2003
- Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiencyKidney International, 2002
- Myopericarditis caused by cyclophosphamide used to mobilize peripheral blood stem cells in a myeloma patient with renal failureBone Marrow Transplantation, 2000
- Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factorBlood, 1986
- Bone-Marrow TransplantationNew England Journal of Medicine, 1975
- Bone-Marrow TransplantationNew England Journal of Medicine, 1975
- Water Intoxication in Man After Cyclophosphamide TherapyAnnals of Internal Medicine, 1973